Beginning on May 26 2022, Europe’s current In Vitro Diagnostic Medical Devices Directive (IVDD 98/79/EC) is being replaced with a new regulation, In Vitro Diagnostic Medical Devices Regulation (IVDR). There is a progressive, multi-year rollout transition schedule. As product performance and patient safety are central to our values, PerkinElmer is fully prepared to comply with …

While dual biomarker tests are more established, additional evidence is now confirming that PIGF as a stand-alone marker could be as effective as the established sFlt-1/PlGF ratio for managing preeclampsia. Placental growth factor (PlGF) is an angiogenic protein synthesized by the placenta. A low concentration has been strongly correlated with preeclampsia. There is proof that …

Every year, pre-eclampsia affects 10 million pregnancies around the world, and it is one of the leading causes of maternal mortality and morbidity and leads to over 2.5 million premature births annually. Pre-eclampsia also has long-term consequences affecting both the mother and the baby later in life-but it is a treatable condition if caught early …

Toronto’s North York General Hospital pioneers new screen for genetic disorders Incidence Of Genetic Disorders The numbers are disturbing. An expectant mother at age 25 has about a 1 in 2,200 chance of giving birth to a baby suffering from a genetic disorder, including Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau …